The choice belongs to a cooperation in between Novo and Kallyope from 2018.
发布者：BY MARKETWIRE，转转请注明出处：https://robotalks.cn/novo-nordisk-exercises-option-to-license-molecule-for-potential-obesity-treatment/
Novo Nordisk exercises option to license molecule for potential obesity treatment
赞 (0)
关于作者
Major hearing aid companies welcome Apple entry: “An exciting move”
上一篇
17 9 月, 2024 11:18 上午
Novo Nordisk reports typical side effect profile for weight loss hope
下一篇
17 9 月, 2024 11:18 上午
相关推荐
-
Pirelli soft rears for Vietti’s success in Moto2™ and Alonso’s in Moto3™
The 2024 Malaysian Grand Prix, held at the Sepang International Circuit, finished with triumphes for Celestino Vietti (Red Bull KTM Ajo/Kalex) in Moto2 ™ and David Alonso (CFMOTO G…
-
Yamaha Motor: sintesi dei risultati consolidati – Per la prima metà dell'esercizio fiscale che si concluderà il 31 dicembre 2024
IWATA, Giappone–( ORGANIZATION CABLE)– Yamaha Electric Motor Co., Ltd. (Tokyo: 7272) ha annunciato i suoi risultati aziendali consolidati per la prima metà dell’ …
-
President Donald Trump’s advanced air mobility policies will pile the pressure on regulators
By Philip Butterworth-Hayes ” Loads of firms in the United States and China are leading the way to establish electrical liftoff and touchdown lorries for households and peopl…
-
Apple asks court to dismiss Justice Department’s antitrust lawsuit
Apple Inc. has actually asked for the termination of a Justice Division claim that declares its organization methods in the mobile phone market violation antitrust guidelines. The …
-
Epic APIs move to USCDI v3
New information aspects pertaining to social chauffeurs of wellness, such as references to social solutions, enhance standards-based info exchange with digital wellness documents, …
